Australia And New Zealand Diagnostic Imaging Equipment Market

Australia And New Zealand Diagnostic Imaging Equipment Market Analysis

The Australia and New Zealand Diagnostic Imaging Equipment Market size is estimated at USD 1.03 billion in 2025, and is expected to reach USD 1.42 billion by 2030, at a CAGR of 6.48% during the forecast period (2025-2030). Demand scales with chronic-disease prevalence, rapid AI deployment across modalities, and record public spending on hospital infrastructure in both countries.^{[1]Australian Institute of Health and Welfare, “Chronic conditions and multimorbidity,” aihw.gov.au} Additional momentum comes from private-equity consolidation of imaging chains, helium-free MRI innovations that curb running costs, and teleradiology networks that extend specialist reach into sparsely populated regions. Capital-cost headwinds, sonographer shortages, and radio-isotope logistics temper growth yet are being offset by flexible finance models, national training grants, and modality-agnostic rebate reform. Overall, the Australia & New Zealand diagnostic imaging equipment market continues to benefit from synchronized policy, technology, and investment cycles that favor sustained equipment renewal and fleet expansion.

Australia And New Zealand Diagnostic Imaging Equipment Market Trends and Insights

Rise in Prevalence of Chronic Diseases

Cardiovascular disease and cancer remain leading death drivers, keeping demand for routine multimodal scans high. Indigenous Australians lose nearly 240,000 healthy life-years annually from illness, prompting targeted imaging subsidies in underserved regions.^{[2]Taylor & Francis, “Australian Burden of Disease Study,” tandfonline.com} New Zealand expects cancer diagnoses to touch 25,000 a year, boosting need for oncology PET-CT capacity. Vendors now bundle AI triage engines such as GE HealthCare’s CareIntellect to accelerate report delivery for complex oncology pathways. National health data agencies standardize coding to track chronic-disease imaging volumes, supporting predictable equipment upgrades.

Growing Geriatric Population

Australia’s over-65 cohort expands by roughly 3.3% annually, raising incidences of osteoporotic fractures and neurodegenerative disorders that demand age-adapted imaging. Policy frameworks under the National Medical Workforce Strategy address geographic maldistribution that leaves rural elderly communities short of radiology services. New Zealand’s Te Whatu Ora implements facility modernization so older adults access MRI and CT on-site rather than traveling long distances. Helium-free MRI such as Siemens MAGNETOM Flow reduces cryogen dependency while incorporating mood-lighting and noise dampening, addressing comfort concerns for elderly scans. Virtual-care megatrends project remote check-ins with integrated image sharing, shrinking repeat hospital visits for seniors.

Increased Adoption of Advanced Imaging Technologies

Annalise.ai’s CT Brain model, live in 120 Sonic Healthcare sites, improves stroke-lesion detection by 45% and showcases local AI commercialization aptitude. Canon’s Aquilion ONE INSIGHT Edition integrates machine learning for organ-adaptive dose optimization and recently won the 2024 Minnies Award. Handheld ultrasound accelerates point-of-care adoption, with GE’s Vscan Air rated best for workflow and image quality by domain experts. Regulators have introduced fast-track files for software-as-a-medical-device so hospitals can pilot AI within shorter procurement cycles.

Private-Sector Centre Consolidation

Private equity deployed USD 4.5 billion across Australian healthcare in 2022, with diagnostic imaging the headline target. Affinity Equity’s USD 965 million move for Lumus Imaging creates a 150-site network that can standardize AI platforms and negotiate national service contracts. Integral Diagnostics’ merger with Capitol Health positions the enlarged group to deploy Aidoc triage software across both countries, improving workflow automation. Larger chains gain leverage to secure bulk-billing volumes under Medicare reforms that aim for 90% GP billing rates by 2030.

Capital Cost of Advanced Modalities

High capital expenditure requirements for next-generation imaging systems create procurement barriers, particularly for smaller healthcare facilities. High-end 3 T MRI or spectral CT can exceed USD 3 million per unit, a threshold that strains district hospitals. Vendor finance packages and leasing are expanding yet smaller New Zealand sites still delay upgrades until depreciation schedules end. Australia’s equipment-lifespan rules grant exemptions for early replacement if efficiency gains are proven, encouraging helium-free swaps. Regulatory compliance costs add complexity, with TGA application audit updates focusing on high-risk devices requiring comprehensive documentation for conformity assessments.

Workforce Shortage of Sonographers

Australia lacks roughly 3,000 qualified sonographers. New Zealand faces similar challenges, with only one university training general sonographers, creating a shortage that exceeds 120 full-time equivalent positions. Private practices conduct 70% of ultrasounds but offer limited placements for trainees, creating a bottleneck that affects appointment wait times.^{[3]Australasian Sonographers Association, “Workforce Australia,” sonographers.org} The ASA requests USD 3.466 million over three years to support clinical training placements and regulatory inclusion, aiming to address the 15-year workforce shortage.

Segment Analysis

By Modality: AI Integration Drives CT Expansion

Computed tomography posted the quickest 7.97% CAGR, helping the Australia & New Zealand diagnostic imaging equipment market diversify beyond ultrasound leadership. The CT upswing aligns with bedside units such as Siemens SOMATOM On.site that bring neuro imaging directly to intensive-care beds. Ultrasound remains indispensable across obstetrics, emergency, and primary-care pathways because of portability and cost advantages. MRI growth benefits from helium-free magnet launches that trim life-cycle costs by up to 30%. X-ray systems have moved toward flat-panel detectors and smart workflow guidance, while fluoroscopy platforms integrate AI dose-optimization. Nuclear imaging’s progress hinges on isotope supply, yet PET-CT retains niche strength in oncology staging backed by rebate increases. Mammography manufacturers add short scan times and AI lesion triage to meet breast-screen mandates. Together these upgrades sustain a healthy replacement cycle that underpins modality-level revenue expansion inside the Australia & New Zealand diagnostic imaging equipment market.

The segment’s technology race fosters multi-vendor AI ecosystems where algorithms from local firms like Harrison.ai can be deployed across Canon, GE, or Philips hardware. Vendor neutrality helps private imaging chains standardize analytics fleetwide. As reimbursement now rewards quality metrics instead of raw throughput, software that cuts repeat scans or accelerates diagnosis holds commercial upside. This environment keeps CT and MRI demand resilient even when capital budgets tighten. The Australia & New Zealand diagnostic imaging equipment industry therefore witnesses continuous modality innovation that aligns clinical outcomes with cost-containment goals.

By Portability: Mobile Systems Gain Momentum

Fixed rooms still represent 81.84% revenue thanks to comprehensive capabilities, yet mobile and handheld devices are starting to reshape workflows within the Australia & New Zealand diagnostic imaging equipment market. Handheld ultrasound alone recorded more than 2,600 emergency-department scans across regional hospitals with 94% diagnostic utility. Mobile CT and MRI reduce patient transfers, lowering in-hospital complication risk. Rural outreach programs leverage truck-mounted magnet units, creating new capital-leasing opportunities for vendors.

Rising point-of-care adoption also reflects clinician demand for real-time triage in primary settings. Artificial intelligence embedded in devices like Philips Lumify automates measurement tasks, which broadens user segments beyond specialist radiologists. Regulatory authorities now provide accelerated routes for low-risk portable devices, shortening time to market. Collectively, these forces push portability CAGR to 7.12%, reinforcing the decentralization trend that drives incremental equipment sales across the Australia & New Zealand diagnostic imaging equipment market.

By Application: Cardiology Accelerates Growth

Oncology delivered a 25.08% share in 2024 as scan volumes rose in tandem with higher cancer incidence. Cardiology, however, displays the strongest 7.81% forecast CAGR due to growing cardiovascular morbidity, new CT-FFR workflows, and AI-based echo automation. GE HealthCare’s Revolution Vibe CT offers unlimited one-beat cardiac imaging, cutting motion artifacts and reducing beta-blocker pre-medication needs.

Neurology rides on stroke program investments, with AI triage halving door-to-needle time for thrombolysis. Orthopedics benefits from upright CT that scans weight-bearing joints, improving surgical planning. Gastroenterology uses endoscopic ultrasound hybrids for lesion assessment, while women’s-health ultrasound integrates advanced placenta-accretion markers. Cross-fertilization between applications ensures steady scanner utilization and secures annuity service contracts that enlarge the Australia & New Zealand diagnostic imaging equipment market size.

By End User: Imaging Centers Expand Rapidly

Hospitals held 69.95% share in 2024 thanks to acute-care dominance, yet dedicated imaging centers race ahead with a 7.68% CAGR as consolidation unlocks scale. Affinity Equity’s Lumus Imaging rollout advances center count and leads to bulk purchasing that lowers per-scan costs. Sonic Healthcare’s network deploys AI across 120 sites, showing how centralized IT can upgrade diagnostic quality quickly.

Primary-care clinics strengthen triage capability through handheld ultrasound, shortening referral loops and alleviating hospital bottlenecks. Mixed-model chains that pair imaging with pathology services also emerge, capturing cross-selling synergies. The Australia & New Zealand diagnostic imaging equipment market therefore sees end-user segmentation widen, providing vendors multiple purchase channels.

Geography Analysis

Australia accounted for 84.78% revenue in 2024 driven by a USD 69.8 million MRI licensing expansion and a USD 266.9 million nuclear-medicine rebate pool that together lifted scan volumes across urban and regional sites. Workforce gaps remain acute, with a deficit of 3,000 sonographers pushing scan wait times beyond 30 days in some states. Supply-chain vulnerabilities include technetium-99m outages and imported helium for legacy magnets, yet fast adoption of helium-light platforms mitigates risk.

New Zealand posts the faster 7.07% CAGR on the back of a record USD 7 billion health-funding uplift that ring-fences USD 1 billion for hospital diagnostic modernization. The Government Policy Statement on Health demands equitable access for Māori and rural populations, steering capital toward mobile units and community hubs. Device regulation under Medsafe exploits a mutual-recognition pact with Australia, trimming vendor complexity. Workforce plans target 85 radiation oncologists by 2031 and include incentives for overseas recruitment.

Across both countries, the policy emphasis on timely imaging aligns with the Needs-Based Funding frameworks, which channel blended payments to providers who achieve service-level benchmarks. This integrated approach supports sustainable capital allocation and underpins a resilient long-run outlook for the Australia & New Zealand diagnostic imaging equipment market.

Competitive Landscape

Market power is shared by multinational OEMs—Siemens Healthineers, GE HealthCare, Philips, Canon, and Fujifilm—alongside fast-growing AI specialists such as Annalise.ai and Harrison.ai. The top five equipment suppliers collectively control a significant share of installed systems, while service chains like Sonic Healthcare, Integral Diagnostics, Lumus Imaging, and I-Med network broaden purchasing influence. Harrison.ai secured USD 112 million in 2025 to refine multi-modality algorithms now used by half of Australian radiologists and covering 6 million patients each year.

Strategic alliances move the needle. GE HealthCare teams with NVIDIA to co-develop autonomous X-ray positioning and ultrasound scanning, addressing staff shortages and boosting throughput. Siemens introduces Ciartic Move, a self-driving C-arm that cuts intra-operative imaging time by up to 50%. Philips’ BlueSeal helium-light MRI reduces energy use by 40 MWh annually per system, securing eco-credibility and appealing to hospital-sustainability charters.

Disruptive entrants include Micro-X, which won a USD 16.4 million ARPA-H grant to create a full-body mobile CT that may challenge incumbent scanner architecture. AI interoperability remains the pivot on which providers choose vendors, pushing legacy suppliers to open software interfaces. These dynamics sustain competitive intensity even as the Australia & New Zealand diagnostic imaging equipment market gradually concentrates through mergers and platform standardization.